SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-014917
Filing Date
2019-10-03
Accepted
2019-10-02 19:38:03
Documents
8
Period of Report
2019-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44895
2 ex2-1.htm EX-2.1 1011116
3 ex10-1.htm EX-10.1 136997
4 ex10-2.htm EX-10.2 96931
5 ex10-3.htm EX-10.3 104774
6 ex10-4.htm EX-10.4 234575
7 ex99-1.htm EX-99.1 20644
8 ex99-1_01.jpg GRAPHIC 3264
  Complete submission text file 0001493152-19-014917.txt   1655790
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 191133909
SIC: 2835 In Vitro & In Vivo Diagnostic Substances